Global C-reactive Protein Testing Market size was valued at US$ 1.66 Bn. in 2022 and the total revenue is expected to grow at CAGR 1.5% through 2023 to 2029, reaching nearly US$ 1.85 Bn.C-reactive Protein Testing Market Overview:
C-reactive Protein Test is a blood tear that measures the level of C- reactive protein. This test identifies different types of infection and diseases that cause inflammation such as Cancer, Cardiovascular disease, Arthritis, etc. C-reactive Protein Test can estimate the risk of a person suffering from heart attack and stroke. Advancements in Nanotechnological tools are expected to provide a lucrative perspective in designing portable bioanalytical assays with high specificity and sensitivity, faster response time, and multiplexing capabilities for onsite accurate disease diagnosis and monitoring. As increasing chronic disease among the population, the demand for this test is increasing.To know about the Research Methodology :- Request Free Sample Report
C-reactive Protein Testing Market Dynamics:
With increasing cases of Cardiovascular disorder across the globe and research and development to update the C-reactive Protein Testing methods, these are the major factors to grow the C-reactive Protein Testing market. AS per the research conducted by American Heart Association (AHA) in 2019, Cardiovascular disorder results in more than 801,000 deaths in the US, and nearly 2,200 patients have died because of Cardiovascular disorder. In addition, the growing elderly population coupled with rising cases of diabetes mellitus are also driving the C-reactive Protein Testing market. Gastrointestinal diseases coupled with subsequent demand for robust disease testing protocols has driven the market National Institute of Health and Care Excellence has recommended the usage of POC CRP testing in primary care of adult patients diagnosed with respiratory tract infection. Initiatives undertaken by government agencies to increase awareness as well as uptake of point of care are factors driving the market. Increase in funds and investments for research entities that are engaged in performing research activities in the area, boost, and market progression. According to the World Heart Federation, coronary heart disease is the leading cause of death worldwide. An estimated 3.8 million men and 3.4 million women die each year from coronary heart disease. Plasmonic Nanoparticles (PNPs) are among the tools that can be used for biosensing applications owing to their versatile optical properties. Aidan offers easy-to-use Quickread go CRP tests and a portable QuikRead go instrument for quantitative measurement of C-reactive protein. Companies such as Abbott and Aidian offer products that can be used as supportive diagnostic tools in the management of COVID-19 infection.C-reactive Protein Testing Market Segment Analysis:
Based on the Assay Type, The C-reactive Protein Testing Market is segmented into Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others. The ELISA segment is sub-segmented into the Clinical and Non-Clinical. The Immunoturbidimetric Assay segment dominated the market and held the largest market share of 48.5% in the year 2022. This segment is anticipated to grow further with the highest CAGR during the forecast period. The application of this technique in several chronic disorders of the cardiac and respiratory systems is expected to dominate this segment by the end of 2029. Development in the Chemiluminescence Immunoassay technique to provide accurate results is expected to propel the market growth by driving the segment.Based on the Application, The C - reactive protein Testing Market is segmented into Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Endometriosis. The cardiovascular Diseases segment dominated the market with the largest market share of 21.8% in the year 2022. An increase in the prevalence of CVDs is the major factor contributing to the growth of the market. Adoption of a sedentary lifestyle, obesity, hypertension, and diabetes are a few risk factors associated with CVDs. The Cancer segment held the second-largest market share in the year 2022. According to WHO, there are 1.9 Mn. deaths and 3.7 Mn. new cancer cases every year in the European region. Hence, there is a need for large-scale adoption of POC CRP testing solutions. Based on the End User, The C-reactive Protein Testing Market is segmented into Hospitals, Clinics, and Diagnostics Labs. The Diagnostics Labs segment dominated the market and is expected to grow with the highest CAGR during the forecast period. C-reactive Protein Testing is used for diagnosis purposes only to recognize the disease condition and infection in the individual. This segment held a market share of 27.4% in the year 2022. Hospitals are the second largest segment and dominated the market during the forecast period.
Regional Insights:
North America dominated the C-reactive Protein Testing Market with the largest market share of 41.4 % in 2022. It is also expected to register at a CAGR of 8.6% during the forecast period. A rise in geriatric population is a key factor responsible for market growth. According to population predictions from the United States Census Bureau, the number of Americans aged 65 and more will increase to approximately 95 Mn. by 2060, up from 52 Mn. in 2019. Furthermore, the total share of people aged 65 and up is expected to climb from 16% to 23% during the forecast period. The market is being driven by rising healthcare expenditure and the adoption of modern healthcare facilities. For example, according to CMS. gov, healthcare spending in the United States increased by 4.6 percent in 2019, reaching USD 3.8 Tr. per person, accounting for 17.7 percent of the country's GDP. Furthermore, favorable reimbursement policies for emergency and non-emergency medical services in the United States and Canada are expected to contribute to market growth. China and India are the main drivers of the Asia Pacific regional market. Japan, South Korea, and Australia are three of the most populous countries in the world. The growth of the market in this region is being fueled by an increase in the number of hospitals and an increase in hospital admissions for emergency care. Furthermore, an increase in the number of road traffic accidents, resulting in an increase in the patient population, is a major driver of market expansion. The objective of the report is to present a comprehensive analysis of the C-reactive Protein Testing Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also helps in understanding the C-reactive Protein Testing Market dynamic, structure by analyzing the market segments and project the C-reactive Protein Testing Market size. Clear representation of competitive analysis of key players by Product, price, financial position, Product portfolio, growth strategies, and regional presence in the C-reactive Protein Testing Market make the report investor’s guide.C-reactive Protein Testing Market Scope: Inquire before buying
C-reactive Protein Testing Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.66 Bn. Forecast Period 2023 to 2029 CAGR: 1.5% Market Size in 2029: US $ 1.85 Bn. Segments Covered: by Assay Type Immunoturbidimetric Assay ELISA Clinical Nonclinical
Chemiluminescence Immunoassay Othersby Application Cardiovascular Diseases Cancer Rheumatoid Arthritis Inflammatory Bowel Disease Endometriosis by End User Hospital Laboratories Independent Clinical Diagnostic Centers Research Organizations Other C-reactive Protein Testing Market, by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)C-reactive Protein Testing Market, Major Key Players
1. Thermo Fisher Scientific, inc. 2. F. Hoffmann-La Roche Ltd. 3. Danaher 4. Quest Diagnostics 5. Siemens Healthineers AG 6. Abbott 7. Merck KGaAA 8. Zoetis 9. Ortho Clinical Diagnostics 10. Getein Biotech, Inc. 11. HORIBA, Ltd 12. Randox Laboratories Ltd. 13. BODITECH MED, INC. 14. AidianFrequently Asked Questions:
1] Which segments are covered in C-reactive Protein Testing Market report? Ans. The segments covered in market report are By Assay Type, By Application and End Users. 2] Which region is expected to hold the highest share in the Hospital Stretchers Market? Ans. North America is expected to hold the highest share in the market 3] What is the market size of C-reactive Protein Testing Market by 2029? Ans. The market size of market by 2029 is US $ 1.85 Bn. 4] Who are the top key players in the Hospital Stretchers Market? Ans Thermo Fisher Scientific, inc., F. Hoffmann-La Roche Ltd., Danaher, Quest, Diagnostics, Siemens Healthineers AG, Abbott, Merck KGaAA, Zoetis, Ortho Clinical Diagnostics, Getein Biotech, Inc., HORIBA, Ltd, Randox Laboratories Ltd. 5] What was the market size of C-reactive Protein Testing Market in 2022? Ans. The market size of market in 2022 was US $ 1.66 Bn.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: C-reactive Protein Testing Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2029 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the C-reactive Protein Testing Market 3.4. Geographical Snapshot of the C-reactive Protein Testing Market , By Manufacturer share 4. C-reactive Protein Testing Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the C-reactive Protein Testing Market 5. Supply Side and Demand Side Indicators 6. C-reactive Protein Testing Market Analysis and Forecast, 2022-2029 6.1. C-reactive Protein Testing Market Size & Y-o-Y Growth Analysis. 7. C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 7.1.1. Immunoturbidimetric Assay 7.1.2. ELISA 7.1.2.1. Clinical 7.1.2.2. Nonclinical 7.1.3. Chemiluminescence Immunoassay 7.1.4. Others 7.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 7.2.1. Cardiovascular Diseases 7.2.2. Cancer 7.2.3. Rheumatoid Arthritis 7.2.4. Inflammatory Bowel Disease 7.2.5. Endometriosis 7.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 7.3.1. Hospital Laboratories 7.3.2. Independent Clinical Diagnostic Centers 7.3.3. Research Organizations 7.3.4. Other 8. C-reactive Protein Testing Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 9.1.1. Genomic 9.1.2. Proteomic 9.1.3. Metabolomic 9.1.4. Imaging 9.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 9.2.1. Alzheimer’s Disease 9.2.2. Parkinson’s Disease 9.2.3. Multiple Sclerosis 9.2.4. Autism Spectrum Disorders 9.2.5. Others 9.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 9.3.1. Hospitals 9.3.2. Clinics 9.3.3. Diagnostics Labs 10. North America C-reactive Protein Testing Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 12. Canada C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 13. Mexico C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 14. Europe C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 15. Europe C-reactive Protein Testing Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 17. France C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 18. Germany C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 19. Italy C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 20. Spain C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 21. Sweden C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 22. CIS Countries C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 23. Rest of Europe C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 24. Asia Pacific C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 25. Asia Pacific C-reactive Protein Testing Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates &Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 27. India C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 28. Japan C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 29. South Korea C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 30. Australia C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 31. ASEAN C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 32. Asia C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 33. Middle East Africa C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 34. Middle East Africa C-reactive Protein Testing Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 36. GCC Countries C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 37. Egypt C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 38. Nigeria C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 39. Rest of ME&A C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 40. South America C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 41. South America C-reactive Protein Testing Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 43. Argentina C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 44. Rest of South America C-reactive Protein Testing Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Assay Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the C-reactive Protein Testing Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward 45.2.3.3. Integration 45.2.3.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Danaher 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. F. Hoffmann-La Roche Ltd. 45.3.3. Quest Diagnostics 45.3.4. Siemens Healthineers AG 45.3.5. Abbott 45.3.6. Merck KGaAA 45.3.7. Zoetis 45.3.8. Ortho Clinical Diagnostics 45.3.9. Getein Biotech, Inc. 45.3.10. HORIBA, Ltd 45.3.11. Randox Laboratories Ltd. 45.3.12. BODITECH MED, INC. 46. Primary Key Insights